ストックスクリーナーアプリを入手
1.43
7.14%
-0.11
アフターアワーズ：
1.46
0.03
+2.10%
Generation Bio Co (GBIO) 最新ニュース
Generation Bio's SWOT analysis: innovative gene therapy stock faces timeline hurdles - Investing.com
Delve Bio and UCSF Publish Research Demonstrating Clinical Utility of Metagenomic Next-Generation Sequencing (mNGS) for Diagnosing Serious Neurological Infections - Business Wire
FY2024 EPS Estimates for Generation Bio Boosted by Analyst - MarketBeat
Earnings Update: Generation Bio Co. (NASDAQ:GBIO) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance
Landlord’s alleged breach doesn’t justify end of rent payments - Massachusetts Lawyers Weekly
Generation Bio Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance UK
Gene Therapy Market to Grow by USD 6.74 Billion from 2024-2028, as Rise in Special Drug Designations Drives Demand with AI-Powered Market EvolutionTechnavio - The Malaysian Reserve
Generation Bio earnings beat by $0.04, revenue topped estimates - Investing.com
Generation Bio Co. (GBIO) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results - The Manila Times
Generation Bio : Reports Recent Business Highlights and Third Quarter 2024 Financial Results Form 8 K - Marketscreener.com
Generation Bio Reports Breakthrough T-Cell Delivery, Slashes Q3 Losses by 46% | GBIO Stock News - StockTitan
Promising Penny Stocks On US Exchanges In November 2024 - Simply Wall St
Researchers Seek to Unlock the Secrets to Human Longevity - Securities.io
Bullish Generation Bio Insiders Loaded Up On US$778.9k Of Stock - Yahoo Finance
ST Launches AI-enhanced Bio-Sensing Chip for Next-gen Wearables - EE Times India
Generation Bio Co. (NASDAQ:GBIO) Short Interest Down 13.4% in October - MarketBeat
Layoff Tracker: Marinus Cuts Employees After Disappointing Phase III Trial - BioSpace
Generation Bio (NASDAQ:GBIO) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT - The Bakersfield Californian
Generation Bio Announces the Presentation of Preclinical - GlobeNewswire
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress - StockTitan
Cubist Systematic Strategies LLC Has $54,000 Stake in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio Co. (NASDAQ:GBIO) Short Interest Down 6.1% in September - MarketBeat
Viral And Non-Viral Vector Manufacturing Market Report 2024-2033 | Size, Trends, Outlook - WhaTech
Alnylam’s founder brings in a $135M series A for City Therapeutics - BioWorld Online
City Therapeutics: $135 Million (Series A) Raised For RNAi-Based Medicine - Pulse 2.0
City Therapeutics Launches with $135 Million Series A Financing to Lead the Future of RNAi-based Medicine - BioSpace
Renaissance Technologies LLC Sells 28,100 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio's SWOT analysis: innovative dna tech propels stock potential - Investing.com India
Generation Bio Co. (NASDAQ:GBIO) Sees Large Increase in Short Interest - MarketBeat
Generation Bio Co. (NASDAQ:GBIO) Short Interest Up 13.8% in September - Defense World
Rhumbline Advisers Buys 5,430 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Bank of New York Mellon Corp Has $527,000 Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Novartis, Generate:Biomedicines Sign Up-to-$1B AI Protein Drug Collaboration - Genetic Engineering & Biotechnology News
Comparative life cycle assessment for PBAT from fossil-derived and 2nd generation biobased feedstocks - ScienceDirect.com
GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy - BioSpace
From 'science fiction to reality': New George Church-founded biotech raises $75M for cell therapy platform - Fierce Biotech
GrowGeneration Corp [GRWG] Investment Guide: What You Need to Know - Knox Daily
Gen Digital: Strong Growth, Good Fundamentals, And Decent Price Action Make A Buy - Seeking Alpha
Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion? - MarketBeat
Insider Sale Alert: Gen Digital Inc [GEN] – Is it Time to sell? - Knox Daily
Cornercap Investment Counsel Inc. Sells 16,746 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio Co. (NASDAQ:GBIO) Shares Bought by Acadian Asset Management LLC - Defense World
Choreo LLC Takes $776,000 Position in Genmab A/S (NASDAQ:GMAB) - MarketBeat
Generation Bio Co. (NASDAQ:GBIO) Shares Sold by Los Angeles Capital Management LLC - Defense World
Generation Bio to Present at the 2024 Cantor Global Healthcare Conference - ForexTV.com
Moderna falls on R&D cuts, filing delays, terminated programs - BioWorld Online
Generation Bio (NASDAQ:GBIO) Stock Price Down 0.4% - MarketBeat
Holdings of Generation Bio Co (GBIO) are aligned with the stars - SETE News
Financial Metrics Check: Generation Bio Co (GBIO)’s Ratios for Trailing Twelve Months - The Dwinnex
The Generation Bio Co (GBIO) had a good session last reading, didn’t it? - US Post News
Next Generation Bio-therapeutics Market to Exhibit - openPR
3.66%
1.11%
大文字化:
|
ボリューム (24 時間):